Paul Chazot
Clinical applications of pitolisant (BF2.649), an inverse agonist at the H3 receptor.
Jean-Charles Schwartz (France)
Functional implications of Histaminergic Neurons Heterogeneity
Patrizio Blandina (Italy)
Translational approaches towards the identification of a histamine H3 receptor antagonist and its’ clinical evaluation for the symptomatic treatment of allergic rhinitis
Nick Carruthers (USA)
Discovery of Novel Agents for the Treatment of CNS Disorders
Jorge Brioni (USA) (given by M. Cowart)
Histamine H3 antagonist properties and efficacy in CNS models
Marlon Cowart (USA)
Histamine H3 and H4 receptors – therapeutic opportunities in airway and inflammatory diseases
Steve Liu (UK)
Histamine as a neurotransmitter in brain: from discovery to novel psychotropic drugs – A short history dedicated to the memory of Sir James Black (1924-2010)
Jean-Charles Schwartz (France)
Medicinal Chemistry & Receptor Modelling
Rob Leurs
Genomics & Bioinformatics
Andràs Falus
n vivo preclinical studies
Abdel Ennaceur
Antibody production & validation
Paul Chazot
Inflammation models
Emanuela Masini
COST Action BM0806 ‘Recent advances in histamine receptor H4R research’